• Hyperuricosuria

• Alaskan Husky Encephalopathy
• Degenerative Myelopathy

• Factor VII Deficiency

• Cone Degeneration (Discovered in the Alaskan Malamute)
• Early-Onset Progressive Polyneuropathy (Discovered in the Alaskan Malamute)
• Primary Ciliary Dyskinesia (Discovered in the Alaskan Malamute)

• Neuronal Ceroid Lipofuscinosis 8 (Discovered in the Alpine Dachsbracke)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Hyperuricosuria

• Canine Multifocal Retinopathy 1
• Hyperuricosuria
• Ichthyosis (Discovered in the American Bulldog)
• Nemaline Myopathy

• Cone-Rod Dystrophy 1
• Cone-Rod Dystrophy 2
• Hyperuricosuria

• Degenerative Myelopathy
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Thrombopathia (Discovered in the Eskimo Spitz)*

• Cone-Rod Dystrophy 2
• Hyperuricosuria

• Hyperuricosuria
• Cone-Rod Dystrophy 1
• Canine Multifocal Retinopathy 1
• Cone-Rod Dystrophy 2
• Osteochondromatosis (Discovered in the American Staffordshire Terrier)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Hereditary Calcium Oxalate Urolithiasis Type 1*

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Disproportionate Dwarfism (Discovered in the Dogo Argentino)*

• Myotonia Congenita
• MDR1 Medication Sensitivity
• Cystinuria Type II-A
• Primary Lens Luxation
• Neuronal Ceroid Lipofuscinosis 12 (Discovered in the Australian Cattle Dog)
• Progressive Rod Cone Degeneration (prcd-PRA)
• Junctional Epidermolysis Bullosa (Discovered in the Australian Cattle Dog Mix)*

• Intestinal Lipid Malabsorption (Discovered in the Australian Kelpie)*

• MDR1 Medication Sensitivity
• Hyperuricosuria
• Cone Degeneration (Discovered in the Alaskan Malamute)
• Neuronal Ceroid Lipofuscinosis 8 (Discovered in the Australian Shepherd)
• Degenerative Myelopathy
• Canine Multifocal Retinopathy 1
• Progressive Rod Cone Degeneration (prcd-PRA)
• Collie Eye Anomaly (CEA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Junctional Epidermolysis Bullosa (Discovered in the Australian Shepherd)*

Craniomandibular Osteopathy (Discovered in the Australian Terrier)*

• Myotonia Congenita
• Cystinuria Type II-A
• Progressive Rod Cone Degeneration (prcd-PRA)

• Fanconi Syndrome
• Progressive Retinal Atrophy (Discovered in the Basenji)
• Pyruvate Kinase Deficiency (Discovered in the Basenji)

• Primary Open Angle Glaucoma (Discovered in Basset Fauve de Bretagne)
• Hyperuricosuria

• Primary Open Angle Glaucoma (Discovered in Petit Basset Griffon Vendeen)

• X-Linked Severe Combined Immunodeficiency (Discovered in the Basset Hound)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Craniomandibular Osteopathy (Discovered in the Basset Hound)*
• Dystrophic Epidermolysis Bullosa (Discovered in the Basset Hound)*
• Lafora Disease (Linkage Test)*
• Thrombopathia (Discovered in the Basset Hound)*

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Pyruvate Kinase Deficiency (Discovered in the Beagle)
• Osteogenesis Imperfecta (Discovered in the Beagle)
• Neonatal Cerebellar Cortical Degeneration
• Intestinal Cobalamin Malabsorption  (Discovered in the Beagle)
• Musladin-Lueke Syndrome
• Hypocatalasia
• Factor VII Deficiency
• Canine Congenital Stationary Night Blindness*
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Lafora Disease (Linkage Test)*

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Collie Eye Anomaly (CEA)

• Spongy Degeneration with Cerebellar Ataxia (Discovered in Belgian Malinois - SDCA1)
• Spongy Degeneration with Cerebellar Ataxia (Discovered in Belgian Malinois - SDCA2)
• Cardiomyopathy*
• Juvenile Mortality (Discovered in the Belgian Shepherd)*
• CNS Atrophy with Cerebellar Ataxia (Discovered in the Belgian Shepherd)*
• Hereditary Ataxia (Discovered in the Belgian Malinois)*
• Hyperuricosuria

• Spongy Degeneration with Cerebellar Ataxia (Discovered in Belgian Malinois - SDCA1)
• Cardiomyopathy and Juvenile Mortality (Discovered in the Belgian Shepherd)*
• CNS Atrophy with Cerebellar Ataxia (Discovered in the Belgian Shepherd)*

• Cardiomyopathy and Juvenile Mortality (Discovered in the Belgian Shepherd)*

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Degenerative Myelopathy
• von Willebrand's Disease type 1

• Progressive Rod Cone Degeneration (prcd-PRA)

• Hyperuricosuria
• Juvenile Laryngeal Paralysis and Polyneuropathy
• Progressive Rod Cone Degeneration (prcd-PRA)

• Degenerative Myelopathy

• Hyperuricosuria
• Canine Multifocal Retinopathy 1

• Progressive Rod Cone Degeneration (prcd-PRA)

• MDR1 Medication Sensitivity
• Intestinal Cobalamin Malabsorption  (Discovered in the Border Collie)
• Sensory Neuropathy
• Dental Hypomineralization
• Trapped Neutrophil Syndrome
• Collie Eye Anomaly (CEA)
• Early Adult Onset Deafness For Border Collies only (Linkage test)
• Hereditary Calcium Oxalate Urolithiasis Type 1*
• Neuronal Ceroid Lipofuscinosis 5 (Discovered in the Border Collie)*

• Shaking Puppy Syndrome (Discovered in the Border Terrier)

• Degenerative Myelopathy

• Hereditary Calcium Oxalate Urolithiasis Type 1*
• Limb-girdle Muscular Dystrophy (Discovered in the Boston Terrier)*

• Exercise-Induced Collapse

• Hemophilia A (Discovered in the Boxer)
• Degenerative Myelopathy

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

Congenital Stationary Night Blindness (CSNB)

• Complement 3 Deficiency

• Laryngeal Paralysis (Discovered in the Bull Terrier Miniature Bull Terrier)*

• Polycystic Kidney Disease
• Primary Lens Luxation
• Lethal Acrodermatitis (Discovered in the Bull Terrier)
• Laryngeal Paralysis (Discovered in the Bull Terrier, Miniature Bull Terrier)*

• Polycystic Kidney Disease
• Primary Lens Luxation
• Lethal Acrodermatitis (Discovered in the Bull Terrier)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Laryngeal Paralysis (Discovered in the Bull Terrier, Miniature Bull Terrier)*

• Ichthyosis (Discovered in the American Bulldog)
• Hyperuricosuria
• Nemaline Myopathy
• Canine Multifocal Retinopathy 1

• Hyperuricosuria
• Canine Multifocal Retinopathy 1
• Hereditary Calcium Oxalate Urolithiasis Type 1*

• Dominant Progressive Retinal Atrophy
• Canine Multifocal Retinopathy 1
• Hereditary Calcium Oxalate Urolithiasis Type 1*

• Canine Multifocal Retinopathy 1
• Dental-Skeletal-Retinal Anomaly (Discovered in the Cane Corso)*

• X-Linked Severe Combined Immunodeficiency (Discovered in the Cardigan Welsh Corgi)
• Degenerative Myelopathy
• Rod-Cone Dysplasia 3
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Hyperuricosuria

• Muscular Dystrophy (Discovered in the Cavalier King Charles Spaniel)
• Xanthinuria (Discovered in the Cavalier King Charles Spaniel)
• Degenerative Myelopathy
• Episodic falling syndrome (EFS)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Dystrophic Epidermolysis Bullosa (Discovered in the Central Asian Ovcharka)

• Degenerative Myelopathy
• Exercise-Induced Collapse
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Neuronal Ceroid Lipofuscinosis 7
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Neuronal Ceroid Lipofuscinosis 7
• Primary Lens Luxation
• Progressive Rod Cone Degeneration (prcd-PRA)
• Canine Multiple Systems Degeneration (Discovered in the Chinese Crested Dog)*
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Primary Lens Luxation

• Primary Open Angle Glaucoma and Lens Luxation (Discovered in Chinese Shar-Pei)

• MDR1 Medication Sensitivity
• Chondrodysplasia
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Hereditary Elliptocytosis
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Pyruvate Dehydrogenase Phosphatase 1 Deficiency
• Exercise-Induced Collapse
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Phosphofructokinase Deficiency
• Exercise-Induced Collapse
• Progressive Rod Cone Degeneration (prcd-PRA)
• Bernard-Soulier Syndrome (Discovered in the Cocker Spaniel)*
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• MDR1 Medication Sensitivity
• Degenerative Myelopathy
• Collie Eye Anomaly (CEA)
• Inflammatory Pulmonary Disease (Discovered in the Rough Collie)*
• Dermatomyositis PAN2 variant (locus A) (Discovered in the Shetland Sheepdog Collie)*
• Dermatomyositis MAP3K7CL variant (locus B) (Discovered in the Shetland Sheepdog Collie)*

• Progressive Retinal Atrophy (Discovered in the Papillon and Phalène)
• von Willebrand's Disease, type 1
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Bandera's Neonatal Ataxia
• von Willebrand's Disease, type 1
• Canine Multifocal Retinopathy 2
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Glycogen Storage Disease Type IIIa (GSD IIIa)
• Exercise-Induced Collapse

• Neuronal Ceroid Lipofuscinosis 1
• Osteogenesis Imperfecta (Discovered in the Dachshund)
• Narcolepsy (Discovered in the Dachshund)
• Mucopolysaccharidosis Type IIIA (Discovered in the Dachshund)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Coat Color Dilution*
• Neurological Defects (Discovered in the Miniature Dachshund)*
• Lafora Disease (Linkage Test)*
• Limb-girdle muscular dystrophy (Discovered in the Miniature Dachshund)*
• Progressive Retinal Atrophy (Discovered in the Miniature Long Haired Dachshund)*

• Neuronal Ceroid Lipofuscinosis 1
• Osteogenesis Imperfecta (Discovered in the Dachshund)
• Narcolepsy (Discovered in the Dachshund)
• Mucopolysaccharidosis Type IIIA (Discovered in the Dachshund)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Coat Color Dilution*
• Neurological Defects (Discovered in the Miniature Dachshund)*
• Lafora Disease (Linkage Test)*
• Limb-girdle muscular dystrophy (Discovered in the Miniature Dachshund)*

• Neuronal Ceroid Lipofuscinosis 1
• Osteogenesis Imperfecta (Discovered in the Dachshund)
• Cone-Rod Dystrophy
• Narcolepsy (Discovered in the Dachshund)
• Mucopolysaccharidosis Type IIIA (Discovered in the Dachshund)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Coat Color Dilution*
• Neurological Defects (Discovered in the Miniature Dachshund)*
• Lafora Disease (Linkage Test)*
• Limb-girdle muscular dystrophy (Discovered in the Miniature Dachshund)*

• Neuronal Ceroid Lipofuscinosis 1
• Osteogenesis Imperfecta (Discovered in the Dachshund)
• Narcolepsy (Discovered in the Dachshund)
• Mucopolysaccharidosis Type IIIA (Discovered in the Dachshund)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Neuronal Ceroid Lipofuscinosis 1
• Osteogenesis Imperfecta (Discovered in the Dachshund)
• Cone-Rod Dystrophy
• Narcolepsy (Discovered in the Dachshund)
• Mucopolysaccharidosis Type IIIA (Discovered in the Dachshund)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Acute Respiratory Distress Syndrome
• Hyperuricosuria

• Acute Respiratory Distress Syndrome
• Hyperuricosuria
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• MDR1 Medication Sensitivity
• Primary Lens Luxation
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Hyperuricosuria

• von Willebrand's Disease, type 1
• Deafness and Vestibular Dysfunction (Discovered in Doberman Pinscher)
• Bilateral Deafness and Vestibular Dysfunction (Discovered in Dobermann) MYO7A gene variant*
• Dilated Cardiomyopathy (Discovered in the Doberman) (variants 1-4)*

• Focal Non-Epidermolytic Palmoplantar Keratoderma
• Canine Multifocal Retinopathy 1

• von Willebrand's Disease, type 1

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Spongy Degeneration with Cerebellar Ataxia (Discovered in Belgian Malinois - SDCA2)
• Inflammatory Myopathy (Discovered in the Dutch Shepherd Dog)*

• Neuronal Ceroid Lipofuscinosis 8 (Discovered in the English Setter)

• MDR1 Medication Sensitivity
• Progressive Rod Cone Degeneration (prcd-PRA)
• Collie Eye Anomaly (CEA)

• Phosphofructokinase Deficiency
• Degenerative Myelopathy
• QT Syndrome
• Acral Mutilation Syndrome
• X-Linked Tremors
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Familial Nephropathy (FN) (Discovered in the English Cocker Spaniel)*

• Muscular Dystrophy (Discovered in the Cavalier King Charles Spaniel)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Cerebellar Hypoplasia

• Factor VII Deficiency
• Progressive Early-Onset Cerebellar Ataxia

• Canine Multifocal Retinopathy 3
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• POMC

• Spinocerebellar Ataxia with Myokymia and/or Seizures

• Spinocerebellar Ataxia with Myokymia and/or Seizures
• Congenital Hypothyroidism (Discovered in the Toy Fox and Rat Terrier)
• Primary Lens Luxation

• Van den Ende-Gupta Syndrome
• Degenerative Myelopathy
• Primary Lens Luxation

• Canine Multifocal Retinopathy 1
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Hyperuricosuria

• Acral Mutilation Syndrome

• Severe Combined Immunodeficiency (Discovered in Frisian Water Dogs)

• Primary Lens Luxation
• Hyperuricosuria

• von Willebrand's Disease, type 1
• Glycogen Storage Disease Type Ia (Discovered in the German Pinscher)*

• MDR1 Medication Sensitivity
• Hyperuricosuria
• Mucopolysaccharidosis Type VII (Discovered in the German Shepherd Dog)
• Hemophilia A (Discovered in the German Shepherd Dog - Variant 2)
• Cone Degeneration (Discovered in the German Shepherd Dog)
• Degenerative Myelopathy
• Hemophilia A (Discovered in the German Shepherd Dog - Variant 1)
• X-Linked Ectodermal Dysplasia
• Renal Cystadenocarcinoma and Nodular Dermatofibrosis
• Canine Scott Syndrome
• Canine Leukocyte Adhesion Deficiency (CLAD), type III

• Cone Degeneration (Discovered in the German Shorthaired Pointer)
• von Willebrand's Disease, type 2
• Neuronal Ceroid Lipofuscinosis 8 (Discovered in the Australian Shepherd)
• Acral Mutilation Syndrome
• Hyperuricosuria

• Hyperuricosuria

• von Willebrand's Disease, type 2
• Exercise-Induced Collapse

• Muscular Dystrophy (Discovered in the Golden Retriever)
• Dystrophic Epidermolysis Bullosa (Discovered in the Golden Retriever)
• Degenerative Myelopathy
• Sensory Ataxic Neuropathy
• Progressive Retinal Atrophy (Discovered in the Golden Retriever - GR-PRA1 variant)
• Congenital Myasthenic Syndrome (Discovered in the Golden Retriever)
• Progressive Rod Cone Degeneration (prcd-PRA)
• Congenital Eye Malformations (Discovered in the Golden Retriever)*
• Ichthyosis Type 2 (Discovered in the Golden Retriever)*
• Neuronal Ceroid Lipofuscinosis 5 (Discovered in the Golden Retriever)*
• Progressive Retinal Atrophy (GR-PRA2) (Discovered in the Golden Retriever)*

• Cerebellar Ataxia

• Centronuclear Myopathy (Discovered in the Great Dane)
• Ichthyosis (Discovered in the Great Dane)

• Glanzmann Thrombasthenia Type I (Discovered in Great Pyrenees)
• Canine Multifocal Retinopathy 1
• Hyperuricosuria

• P2RY12-associated Bleeding Disorder

• Early-Onset Progressive Polyneuropathy (Discovered in the Greyhound)
• Hereditary Nasal Parakeratosis (Discovered in the Greyhound)

• Congenital Myasthenic Syndrome (Discovered in the Heideterrier)*

• Collie Eye Anomaly (CEA)

• Rod-Cone Dysplasia 1
• Globoid Cell Leukodystrophy (Discovered in the Irish Setter)

• Hereditary Footpad Hyperkeratosis
• Darier Disease (Discovered in the Irish Terrier)*

• Hyperekplexia or Startle Disease

• Amelogenesis Imperfecta
• Progressive Retinal Atrophy 1 (Discovered in the Italian Greyhound)
• Congenital Muscular Dystrophy (Discovered in the Italian Greyhound)*

• GM1 Gangliosidosis (Discovered in the Shiba)

• Degenerative Myelopathy
• Factor XI Deficiency
• von Willebrand's Disease, type 1

• Intestinal Cobalamin Malabsorption (Discovered in the Komondor)

• von Willebrand's Disease, type 3 (Discovered in the Kooiker Hound)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Hyperuricosuria
• von Willebrand's Disease, type 1
• Hereditary Footpad Hyperkeratosis

• Progressive Rod Cone Degeneration (prcd-PRA)

• Hyperuricosuria

• Lagotto Storage Disease
• Hyperuricosuria
• Benign Familial Juvenile Epilepsy
• Progressive Rod Cone Degeneration (prcd-PRA)

• Primary Lens Luxation

• Primary Lens Luxation
• Progressive Rod Cone Degeneration (prcd-PRA)
• Collie Eye Anomaly (CEA)
• Enamel Hypoplasia (Discovered in the Lancashire Heeler)*

• Cystinuria Type I-A
• Muscular Dystrophy (Discovered in the Landseer)

• Canine Multifocal Retinopathy 3
• Progressive Rod Cone Degeneration (prcd-PRA)
• Progressive Retinal Atrophy (Discovered in the Lapponian Herder)*

• Hemophilia B (Discovered in the Lhasa Apso)
• Progressive Retinal Atrophy (Discovered in the Lhasa Apso)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Primary Lens Luxation

• von Willebrand's Disease, type 1

• Xanthinuria (Discovered in the Toy Manchester Terrier)
• von Willebrand's Disease, type 1
• Progressive Rod Cone Degeneration (prcd-PRA)
• Juvenile Dilated Cardiomyopathy (Discovered in the Toy Manchester Terrier)*

• Progressive Rod Cone Degeneration (prcd-PRA)

• Dominant Progressive Retinal Atrophy
• Canine Multifocal Retinopathy 1

• MDR1 Medication Sensitivity

• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• MDR1 Medication Sensitivity
• Hyperuricosuria
• Cone Degeneration (Discovered in the Alaskan Malamute)
• Canine Multifocal Retinopathy 1
• Progressive Rod Cone Degeneration (prcd-PRA)
• Collie Eye Anomaly (CEA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Startle Disease (Discovered in the Miniature American Shepherd)*

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Mucopolysaccharidosis VI (Discovered in the Miniature Pinscher)*

• Hyperuricosuria

• Mucopolysaccharidosis Type IIIA (Discovered in the New Zealand Huntaway)

• Cystinuria Type I-A

• Progressive Early-Onset Cerebellar Ataxia
• Progressive Rod Cone Degeneration (prcd-PRA)

• Epidermolytic Hyperkeratosis
• Macrothrombocytopenia
• Muscular Dystrophy (Discovered in the Norfolk Terrier)

• Hereditary Ataxia (Discovered in the Norwegian Buhund)

• Chondrodysplasia
• Early Retinal Degeneration (Discovered in the Norwegian Elkhound)
• Progressive Rod Cone Degeneration (prcd-PRA)

• Primary Lens Luxation
• Cystic Renal Dysplasia and Hepatic Fibrosis

• Cleft Lip & Palate with Syndactyly
• Cleft Palate
• Progressive Rod Cone Degeneration (prcd-PRA)
• Collie Eye Anomaly (CEA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Cerebellar Ataxia
• MDR1 Medication Sensitivity
• Hemophilia A (Discovered in Old English Sheepdog)
• Exercise-Induced Collapse
• Primary Ciliary Dyskinesia

• Hyperuricosuria

• Hyperuricosuria

• Spinocerebellar Ataxia with Myokymia and/or Seizures
• Hyperuricosuria
• Spinocerebellar Ataxia (Late-Onset Ataxia)
• Severe Combined Immunodeficiency
• Primary Lens Luxation
• Enamel Hypoplasia (Discovered in the Parson Russell Terrier)
• Juvenile Encephalopathy (Discovered in the Parson Russell Terrier)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Primary Lens Luxation

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Degenerative Myelopathy
• Rod-Cone Dysplasia 3
• von Willebrand's Disease, type 1
• Exercise-Induced Collapse
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Progressive Rod Cone Degeneration (prcd-PRA)

• Acral Mutilation Syndrome

• Juvenile Cataract (Discovered in the Wirehaired Pointing Griffon)*

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Hyperuricosuria
• Hereditary Vitamin D-Resistant Rickets Type II
• Progressive Rod Cone Degeneration (prcd-PRA)

• Osteochondrodysplasia
• von Willebrand's Disease, type 1
• Progressive Rod Cone Degeneration (prcd-PRA)
• Hyperuricosuria

• Osteochondrodysplasia
• von Willebrand's Disease, type 1
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Hyperuricosuria

• Neonatal Encephalopathy with Seizures
• Degenerative Myelopathy
• von Willebrand's Disease, type 1
• Progressive Rod Cone Degeneration (prcd-PRA)
• Hyperuricosuria

• Osteochondrodysplasia
• von Willebrand's Disease, type 1
• GM2 Gangliosidosis (Discovered in the Toy Poodle)
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Hyperuricosuria

• Osteochondrodysplasia
• von Willebrand's Disease, type 1
• GM2 Gangliosidosis (Discovered in the Toy Poodle)
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)* and Intervertebral Disc Disease (IVDD) Risk*

• Progressive Rod Cone Degeneration (prcd-PRA)

• Progressive Rod Cone Degeneration (prcd-PRA)

• Early-onset PRA (Discovered in the Portuguese Water Dog)
• GM1 Gangliosidosis (Discovered in the Portuguese Water Dog)
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Hyperuricosuria

• Canine Multifocal Retinopathy 1

• Degenerative Myelopathy
• May-Hegglin Anomaly
• Pyruvate Kinase Deficiency (Discovered in the Pug)

• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Primary Lens Luxation

• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Juvenile Myoclonic Epilepsy
• Degenerative Myelopathy
• Early Onset Adult Deafness (Discovered in the Rhodesian Ridgeback)*

• Juvenile Laryngeal Paralysis and Polyneuropathy
• Myotubular Myopathy
• Neuroaxonal Dystrophy (Discovered in the Rottweiler)
• Hereditary Calcium Oxalate Urolithiasis Type 1*
• Palmoplantar Hyperkeratosis (Discovered in the Rottweiler)*
• Sensorineural Deafness (Discovered in the Rottweiler)*

• Lamellar Ichthyosis
• Spinocerebellar Ataxia with Myokymia and/or Seizures
• Hyperuricosuria
• Spinocerebellar Ataxia (Late-Onset Ataxia)
• Congenital Myasthenic Syndrome (Discovered in the Jack Russell Terrier)
• Severe Combined Immunodeficiency
• Primary Lens Luxation
• Progressive Rod Cone Degeneration (prcd-PRA)

• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• X-Linked Progressive Retinal Atrophy 1
• X-Linked Hereditary Nephropathy (Discovered in the Samoyed)

• Hyperuricosuria
• Generalized Progressive Retinal Atrophy (Discovered in the Schapendoes)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Progressive Rod Cone Degeneration (prcd-PRA)

• Hyperuricosuria
• Dilated Cardiomyopathy (Discovered in the Schnauzer)
• Fetal Onset Neuroaxonal Dystrophy
• Factor VII Deficiency
• Progressive Rod Cone Degeneration (prcd-PRA)

• Persistent Müllerian Duct Syndrome
• X-Linked Progressive Retinal Atrophy 2
• Spondylocostal Dysostosis
• Myotonia Congenita (Discovered in the Miniature Schnauzer)
• Demyelinating Neuropathy
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Dilated Cardiomyopathy (Discovered in the Schnauzer)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Leukodystrophy (Discovered in the Standard Schnauzer)*

• Factor VII Deficiency

• Craniomandibular Osteopathy
• von Willebrand's Disease, type 3 (Discovered in the Scottish Terrier)
• Ligneous Membranitis
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Primary Lens Luxation
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Progressive Rod Cone Degeneration (prcd-PRA)

• MDR1 Medication Sensitivity
• Progressive Retinal Atrophy (Discovered in the Shetland Sheepdog - CNGA1 variant)
• von Willebrand's Disease, type 3 (Discovered in the Shetland Sheepdog)
• Progressive Retinal Atrophy (Discovered in the Shetland Sheepdog - BBS2 variant)
• Collie Eye Anomaly (CEA
• Dermatomyositis, PAN2 variant (locus A) (Discovered in the Shetland Sheepdog Collie*
• Dermatomyositis MAP3K7CL variant (locus B) (Discovered in the Shetland Sheepdog Collie)*

• Prekallikrein Deficiency
• Congenital Dyshormonogenic Hypothyroidism with Goiter (Discovered in the Shih Tzu)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• X-Linked Progressive Retinal Atrophy 1

• MDR1 Medication Sensitivity
• Collie Eye Anomaly (CEA)

• Progressive Rod Cone Degeneration (prcd-PRA)

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Rod-Cone Dysplasia 1a

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Degenerative Myelopathy
• Paroxysmal Dyskinesia
• Protein Losing Nephropathy
• Microphthalmia (Discovered in the Soft-Coated Wheaten Terrier)

• Hyperuricosuria

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*
• Early Onset Progressive Retinal Atrophy (Discovered in the Spanish Water Dog)*

• Cerebral Dysfunction
• von Willebrand's Disease, type 1
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• L-2-Hydroxyglutaric Aciduria
• Congenital Muscular Dystrophy (Discovered in the Staffordshire Bull Terrier)*
• Hereditary Calcium Oxalate Urolithiasis, Type 1*

• Pyruvate Dehydrogenase Phosphatase 1 Deficiency
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Progressive Rod Cone Degeneration (prcd-PRA)

• Progressive Rod Cone Degeneration (prcd-PRA)

• Progressive Retinal Atrophy (Discovered in the Swedish Vallhund)
• Hyperuricosuria

• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Spinocerebellar Ataxia with Myokymia and/or Seizures
• Congenital Hypothyroidism (Discovered in the Tenterfield Terrier)
• Primary Lens Luxation

• Mucopolysaccharidosis Type VII (Discovered in the Brazilian Terrier)

• Progressive Retinal Atrophy Type III
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Progressive Retinal Atrophy Type III
• Primary Lens Luxation
• Progressive Rod Cone Degeneration (prcd-PRA)
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Primary Lens Luxation

• Factor VII Deficiency
• Chondrodystrophy (CDDY)/Intervertebral Disc Disease (IVDD) Risk*

• Primary Lens Luxation

• Pyruvate Kinase Deficiency (Discovered in the West Highland White Terrier)
• Craniomandibular Osteopathy
• Globoid Cell Leukodystrophy (Discovered in Terriers)
• L-2-Hydroxyglutaric Aciduria (Discovered in the Westie)

• Phosphofructokinase Deficiency
• Muscular Hypertrophy (Double Muscling)
• Collie Eye Anomaly (CEA)

• MDR1 Medication Sensitivity

• Hyperuricosuria
• Cerebellar Cortical Degeneration
• Exercise-Induced Collapse